WINDTREE THERAPEUTICS INC /DE/ Operating Cash Flow
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Operating Cash Flow of -$11.44 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.37M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$2.66M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$2.41M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$3.69M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for fiscal 2024 was -$15.40M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for fiscal 2023 was -$13.44M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for fiscal 2022 was -$19.45M.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) operating activities for fiscal 2021 was -$23.66M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$9.03M derived: sum of 2 quarters · filed 2025-11-19 | -$11.44M 10-Q · filed 2025-11-19 | -$15.12M derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | -$2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$5.06M 10-Q · filed 2025-08-19 | -$8.75M derived: sum of 3 quarters · filed 2025-08-19 | -$15.19M derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | -$2.41M 10-Q · filed 2025-05-15 | -$6.09M derived: sum of 2 quarters · filed 2025-05-15 | -$12.54M derived: sum of 3 quarters · filed 2025-11-19 | -$14.86M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | -$3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$10.13M derived: sum of 2 quarters · filed 2025-11-19 | -$12.46M derived: sum of 3 quarters · filed 2025-11-19 | -$15.40M 10-K · filed 2025-04-15 |
| 2024-09-30 | -$6.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$8.77M derived: sum of 2 quarters · filed 2025-11-19 | -$11.72M 10-Q · filed 2025-11-19 | -$15.28M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$5.27M 10-Q · filed 2025-08-19 | -$8.84M derived: sum of 3 quarters · filed 2025-08-19 | -$12.69M derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | -$2.95M 10-Q · filed 2025-05-15 | -$6.51M derived: sum of 2 quarters · filed 2025-05-15 | -$10.37M derived: sum of 3 quarters · filed 2025-05-15 | -$13.87M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$7.42M derived: sum of 2 quarters · filed 2025-04-15 | -$10.92M derived: sum of 3 quarters · filed 2025-04-15 | -$13.44M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | -$7.35M derived: sum of 2 quarters · filed 2024-11-26 | -$9.87M 10-Q · filed 2024-11-26 | -$13.25M derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-06-30 | -$3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$6.02M 10-Q · filed 2024-08-19 | -$9.40M derived: sum of 3 quarters · filed 2024-08-19 | -$13.49M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$2.52M 10-Q · filed 2024-05-15 | -$5.90M derived: sum of 2 quarters · filed 2024-05-15 | -$10.00M derived: sum of 3 quarters · filed 2024-05-15 | -$15.26M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$7.48M derived: sum of 2 quarters · filed 2024-04-16 | -$12.74M derived: sum of 3 quarters · filed 2024-04-16 | -$19.45M 10-K · filed 2024-04-16 |
| 2022-09-30 | -$4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$9.36M derived: sum of 2 quarters · filed 2023-11-09 | -$16.07M 10-Q · filed 2023-11-09 | -$21.00M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$11.97M 10-Q · filed 2023-08-07 | -$16.91M derived: sum of 3 quarters · filed 2023-08-07 | -$22.19M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$6.71M 10-Q · filed 2023-05-15 | -$11.65M derived: sum of 2 quarters · filed 2023-05-15 | -$16.93M derived: sum of 3 quarters · filed 2023-05-15 | -$24.33M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$10.21M derived: sum of 2 quarters · filed 2023-03-31 | -$17.62M derived: sum of 3 quarters · filed 2023-03-31 | -$23.66M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$5.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$12.68M derived: sum of 2 quarters · filed 2022-11-14 | -$18.73M 10-Q · filed 2022-11-14 | -$23.27M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$13.45M 10-Q · filed 2022-08-11 | -$17.99M derived: sum of 3 quarters · filed 2022-08-11 | -$26.25M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$6.05M 10-Q · filed 2022-05-05 | -$10.59M derived: sum of 2 quarters · filed 2022-05-05 | -$18.84M derived: sum of 3 quarters · filed 2022-05-05 | -$25.88M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$12.79M derived: sum of 2 quarters · filed 2022-03-31 | -$19.83M derived: sum of 3 quarters · filed 2022-03-31 | -$25.32M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$8.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$15.29M derived: sum of 2 quarters · filed 2021-11-10 | -$20.78M 10-Q · filed 2021-11-10 | -$26.23M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$7.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$12.52M 10-Q · filed 2021-08-05 | -$17.98M derived: sum of 3 quarters · filed 2021-08-05 | -$21.80M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$5.48M 10-Q · filed 2021-05-13 | -$10.94M derived: sum of 2 quarters · filed 2021-05-13 | -$14.77M derived: sum of 3 quarters · filed 2021-05-13 | -$21.39M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$9.28M derived: sum of 2 quarters · filed 2021-03-29 | -$15.90M derived: sum of 3 quarters · filed 2021-03-29 | -$24.66M 10-K · filed 2021-03-29 |
| 2019-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$10.45M derived: sum of 2 quarters · filed 2020-11-16 | -$19.20M 10-Q · filed 2020-11-16 | -$25.39M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$6.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$15.38M 10-Q · filed 2020-08-14 | -$21.57M derived: sum of 3 quarters · filed 2020-08-14 | -$24.85M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$8.76M 10-Q · filed 2020-05-13 | -$14.95M derived: sum of 2 quarters · filed 2020-05-13 | -$18.23M derived: sum of 3 quarters · filed 2020-05-13 | -$21.99M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | -$9.47M derived: sum of 2 quarters · filed 2020-04-03 | -$13.23M derived: sum of 3 quarters · filed 2020-04-03 | -$15.78M 10-K · filed 2020-04-03 |
| 2018-09-30 | -$3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$7.04M derived: sum of 2 quarters · filed 2019-11-14 | -$9.59M 10-Q · filed 2019-11-14 | -$14.40M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$6.31M 10-Q · filed 2019-08-14 | -$11.12M derived: sum of 3 quarters · filed 2019-08-14 | -$14.50M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$2.55M 10-Q · filed 2019-05-20 | -$7.35M derived: sum of 2 quarters · filed 2019-05-20 | -$10.73M derived: sum of 3 quarters · filed 2019-05-20 | -$16.26M derived: sum of 4 quarters · filed 2019-05-20 |
| 2017-12-31 | -$4.81M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | -$8.18M derived: sum of 2 quarters · filed 2019-04-23 | -$13.71M derived: sum of 3 quarters · filed 2019-04-23 | -$21.05M 10-K/A · filed 2019-04-23 |
| 2017-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$8.90M derived: sum of 2 quarters · filed 2018-11-14 | -$16.24M 10-Q · filed 2018-11-14 | -$23.18M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$5.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$12.86M 10-Q · filed 2018-08-14 | -$19.81M derived: sum of 3 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$7.33M 10-Q · filed 2018-05-21 | -$14.28M derived: sum of 2 quarters · filed 2018-05-21 | ||
| 2016-12-31 | -$6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | -$33.59M 10-K · filed 2018-04-17 | ||
| 2016-09-30 | -$26.64M 10-Q · filed 2017-11-14 | |||
| 2014-09-30 | -$10.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$20.81M derived: sum of 2 quarters · filed 2014-11-07 | -$31.09M 10-Q · filed 2014-11-07 | -$41.12M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | -$9.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$20.26M 10-Q · filed 2014-08-07 | -$30.29M derived: sum of 3 quarters · filed 2014-08-07 | -$40.27M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | -$10.28M 10-Q · filed 2014-05-12 | -$20.31M derived: sum of 2 quarters · filed 2014-05-12 | -$30.29M derived: sum of 3 quarters · filed 2014-11-07 | -$40.50M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | -$10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$20.01M derived: sum of 2 quarters · filed 2014-11-07 | -$30.22M derived: sum of 3 quarters · filed 2014-11-07 | -$40.45M 10-K · filed 2014-03-17 |
| 2013-09-30 | -$9.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$20.18M derived: sum of 2 quarters · filed 2014-11-07 | -$30.42M 10-Q · filed 2014-11-07 | -$39.48M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | -$10.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$20.44M 10-Q · filed 2014-08-07 | -$29.51M derived: sum of 3 quarters · filed 2014-08-07 | -$39.36M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | -$10.23M 10-Q · filed 2014-05-12 | -$19.30M derived: sum of 2 quarters · filed 2014-05-12 | -$29.15M derived: sum of 3 quarters · filed 2014-05-12 | -$37.57M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | -$9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$18.91M derived: sum of 2 quarters · filed 2014-03-17 | -$27.34M derived: sum of 3 quarters · filed 2014-03-17 | -$32.88M 10-K · filed 2014-03-17 |
| 2012-09-30 | -$9.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$18.27M derived: sum of 2 quarters · filed 2013-11-12 | -$23.82M 10-Q · filed 2013-11-12 | -$29.34M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$8.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$13.97M 10-Q · filed 2013-08-08 | -$19.49M derived: sum of 3 quarters · filed 2014-03-17 | -$25.53M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | -$5.55M 10-Q · filed 2013-05-07 | -$11.07M derived: sum of 2 quarters · filed 2014-03-17 | -$17.10M derived: sum of 3 quarters · filed 2014-03-17 | -$23.18M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | -$5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$11.56M derived: sum of 2 quarters · filed 2014-03-17 | -$17.63M derived: sum of 3 quarters · filed 2014-03-17 | -$22.70M 10-K · filed 2014-03-17 |
| 2011-09-30 | -$6.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$12.11M derived: sum of 2 quarters · filed 2012-11-14 | -$17.17M 10-Q · filed 2012-11-14 | -$22.78M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$11.14M 10-Q · filed 2012-08-14 | -$16.75M derived: sum of 3 quarters · filed 2013-03-15 | -$21.69M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$5.07M 10-Q · filed 2012-05-15 | -$10.68M derived: sum of 2 quarters · filed 2013-03-15 | -$15.62M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | -$5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$10.55M derived: sum of 2 quarters · filed 2013-03-15 | -$24.27M 10-K · filed 2013-03-15 | |
| 2010-09-30 | -$4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$18.66M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$13.72M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |